Evidence map›Paper›PMID 35861700›Full record

SynthesisThe Journal of clinical endocrinology and metabolism2022

TSH and FT4 Reference Intervals in Pregnancy: A Systematic Review and Individual Participant Data Meta-Analysis.

Joris A J Osinga, Arash Derakhshan, Glenn E Palomaki, Ghalia Ashoor, Tuija Männistö, Spyridoula Maraka, Liangmiao Chen, Sofie Bliddal, Xuemian Lu, Peter N Taylor and 39 more

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in The Journal of clinical endocrinology and metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

49 authors.

Joris A J OsingaDepartment of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.ORCID 0000-0003-2527-5150
Arash DerakhshanDepartment of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.ORCID 0000-0001-7335-1918
Glenn E PalomakiDepartment of Pathology and Laboratory Medicine, Women & Infants Hospital and Alpert Medical School at Brown University, Providence, RI 02905, USA.
Ghalia AshoorHarris Birthright Research Center for Fetal Medicine, King's College Hospital, London, UK.
Tuija MännistöNorthern Finland Laboratory Center Nordlab and Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.
Spyridoula MarakaDivision of Endocrinology and Metabolism, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
Liangmiao ChenDepartment of Endocrinology and Rui'an Center of the Chinese-American Research Institute for Diabetic Complications, Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Sofie BliddalDepartment of Medical Endocrinology and Metabolism, Copenhagen University Hospital, Rigshospitalet, and Department of Clinical Medicine, Faculty of Health and clinical Sciences, Copenhagen University, Copenhagen, Denmark.ORCID 0000-0002-2456-1019
Xuemian LuDepartment of Endocrinology and Rui'an Center of the Chinese-American Research Institute for Diabetic Complications, Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Peter N TaylorThyroid Research Group, Systems Immunity Research Institute, Cardiff University School of Medicine, Cardiff, UK.ORCID 0000-0002-3436-422X
Tanja G M VrijkotteDepartment of Public and Occupational Health, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.
Fang-Biao TaoDepartment of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University; Anhui Provincial Key Laboratory of Population Health & Aristogenics, Hefei, Anhui, China.
Suzanne J BrownDepartment of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.ORCID 0000-0002-8413-561X
Farkhanda GhafoorDepartment of Research and Innovation, Shalamar Institute of Health Sciences, Lahore, Pakistan.
Kris PoppeEndocrine Unit, Centre Hospitalier Universitaire Saint-Pierre, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Flora VeltriEndocrine Unit, Centre Hospitalier Universitaire Saint-Pierre, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Lida ChatziDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California, CA 90089, USA.
Bijay VaidyaDepartment of Endocrinology, Royal Devon and Exeter Hospital NHS Foundation Trust, University of Exeter Medical School, Exeter, UK.
Maarten A C BroerenLaboratory of Clinical Chemistry and Haematology, Máxima Medical Centre, Veldhoven, The Netherlands.
Beverley M ShieldsDepartment of Medical Statistics, University of Exeter Medical School, Exeter, UK.
Sachiko ItohCenter for Environmental and Health Sciences, Hokkaido University, Sapporo, Japan.
Lorena MossoDepartments of Endocrinology, Pontificia Universidad Catolica de Chile, Santiago, Chile.
Polina V PopovaInstitute of Endocrinology, Almazov National Medical Research Centre, Saint Petersburg, Russia.
Anna D AnopovaInstitute of Endocrinology, Almazov National Medical Research Centre, Saint Petersburg, Russia.
Reiko KishiCenter for Environmental and Health Sciences, Hokkaido University, Sapporo, Japan.
Ashraf AminorroayaIsfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Maryam KianpourIsfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Abel López-BermejoPediatric Endocrinology Research Group, Girona Biomedical Research Institute (IDIBGI), Dr. Josep Trueta Hospital, Girona, Spain.ORCID 0000-0002-5828-8911
Emily OkenDivision of Chronic Disease Research Across the Lifecourse, Department of Population Medicine, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0003-2513-3339
Amna PirzadaShifa Institute of Medical Technology, Shifa International Hospital, Islamabad, Pakistan.
Marina VafeiadiDepartment of Social Medicine, School of Medicine, University of Crete, Heraklion, Crete, Greece.
Wichor M BramerMedical Library, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Eila SuvantoDepartment of Obstetrics and Gynecology and Medical Research Center Oulu, University of Oulu, Oulu, Finland.
Jun YoshinagaFaculty of Life Sciences, Toyo University, Gunma, Japan.
Kun HuangDepartment of Maternal, Child and Adolescent Health, Scientific Research Center in Preventive Medicine; School of Public Health; Anhui Medical University, China.
Judit BassolsMaternal-Fetal Metabolic Research Group, Girona Biomedical Research Institute (IDIBGI), Dr. Josep Trueta Hospital, Girona, Spain.
Laura BoucaiDepartment of Medicine, Division of Endocrinology, Memorial Sloan-Kettering Cancer Center, Weill Cornell University, New York, NY 10065, USA.ORCID 0000-0002-8852-1120
Ulla Feldt-RasmussenDepartment of Medical Endocrinology and Metabolism, Copenhagen University Hospital, Rigshospitalet, and Department of Clinical Medicine, Faculty of Health and clinical Sciences, Copenhagen University, Copenhagen, Denmark.ORCID 0000-0002-5903-3355
Elena N GrinevaInstitute of Endocrinology, Almazov National Medical Research Centre, Saint Petersburg, Russia.
Elizabeth N PearceSection of Endocrinology, Diabetes, and Nutrition, Boston University School of Medicine, Boston, Massachusetts 02118, USA.
Erik K AlexanderDivision of Endocrinology, Hypertension and Diabetes, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 0211, USA.ORCID 0000-0002-1313-2462
Victor J M PopDepartment of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands.
Scott M NelsonSchool of Medicine, University of Glasgow, Glasgow, UK.ORCID 0000-0002-9099-3047
John P WalshDepartment of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.ORCID 0000-0002-1766-2612
Robin P PeetersDepartment of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
Layal ChakerDepartment of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
Kypros H NicolaidesDepartment of Women and Children's Health, Faculty of Life Sciences and Medicine King's College London, London, UK.
Mary E D'AltonDepartment of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York 10032, USA.
Tim I M KorevaarDepartment of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

contextInterpretation of thyroid function tests during pregnancy is limited by the generalizability of reference intervals between cohorts due to inconsistent methodology.

objective(1) To provide an overview of published reference intervals for thyrotropin (TSH) and free thyroxine (FT4) in pregnancy, (2) to assess the consequences of common methodological between-study differences by combining raw data from different cohorts.

methods(1) Ovid MEDLINE, EMBASE, and Web of Science were searched until December 12, 2021. Studies were assessed in duplicate. (2) The individual participant data (IPD) meta-analysis was performed in participating cohorts in the Consortium on Thyroid and Pregnancy.

results(1) Large between-study methodological differences were identified, 11 of 102 included studies were in accordance with current guidelines; (2) 22 cohorts involving 63 198 participants were included in the meta-analysis. Not excluding thyroid peroxidase antibody-positive participants led to a rise in the upper limits of TSH in all cohorts, especially in the first (mean +17.4%; range +1.6 to +30.3%) and second trimester (mean +9.8%; range +0.6 to +32.3%). The use of the 95th percentile led to considerable changes in upper limits, varying from -10.8% to -21.8% for TSH and -1.2% to -13.2% for FT4. All other additional exclusion criteria changed reference interval cut-offs by a maximum of 3.5%. Applying these findings to the 102 studies included in the systematic review, 48 studies could be used in a clinical setting.

conclusionWe provide an overview of clinically relevant reference intervals for TSH and FT4 in pregnancy. The results of the meta-analysis indicate that future studies can adopt a simplified study setup without additional exclusion criteria.

Indexed as

Iodide PeroxidaseThyroxineFemaleHumansPregnancyReference ValuesThyroid Function TestsThyroid GlandThyrotropinIodide PeroxidaseThyrotropinThyroxinefree thyroxine (FT4)pregnancyreference valuesthyroidthyrotropin (TSH)

Identifiers

PMID35861700
PMCPMC9516198

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.